KRAS G12A has been identified in lung, colon, colorectal and rectal adenocarcinoma, and uterine endometrioid carcinoma, while KRAS Q61K has been found in colon, colorectal and pancreatic adenocarcinoma. This evidence concerns the gene KRAS and endometrial endometrioid adenocarcinoma.